Amphenol (NYSE:APH) Stock Rated Buy in New Coverage at Erste Group Bank

Erste Group Bank initiated coverage on shares of Amphenol (NYSE:APH) in a research report released on Wednesday morning, Marketbeat.com reports. The brokerage issued a buy rating on the electronics maker’s stock.

A number of other brokerages have also recently issued reports on APH. Wall Street Zen upgraded Amphenol from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. TD Cowen dropped their target price on shares of Amphenol from $175.00 to $90.00 and set a “hold” rating for the company in a research report on Wednesday, September 9th. Weiss Ratings upgraded shares of Amphenol from a “buy (b)” rating to a “buy (a-)” rating in a report on Thursday, October 8th. Bank of America lifted their price target on shares of Amphenol from $90.00 to $92.50 and gave the company a “buy” rating in a research report on Thursday, July 9th. Finally, Citigroup reiterated a “buy” rating and set a $112.00 price objective (up from $105.00) on shares of Amphenol in a research note on Thursday, October 8th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $98.56.

Amphenol Trading Up 1.3%

Shares of APH opened at $74.00 on Wednesday. The company has a current ratio of 1.89, a quick ratio of 1.41 and a debt-to-equity ratio of 1.10. The firm has a market capitalization of $182.49 billion, a P/E ratio of 37.10, a price-to-earnings-growth ratio of 0.99 and a beta of 1.23. The stock’s fifty day simple moving average is $81.57 and its 200 day simple moving average is $77.49. Amphenol has a twelve month low of $59.01 and a twelve month high of $89.93.

Amphenol (NYSE:APH) last posted its quarterly earnings results on Wednesday, July 29th. The electronics maker reported $0.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.60 by $0.08. The firm had revenue of $8.76 billion during the quarter, compared to the consensus estimate of $8.26 billion. Amphenol had a return on equity of 39.87% and a net margin of 17.73%. The firm’s quarterly revenue was up 55.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.41 earnings per share. Amphenol has set its Q3 2026 guidance at 1.400-1.420 EPS. On average, equities research analysts forecast that Amphenol will post 2.66 earnings per share for the current year.

Amphenol Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 14th. Shareholders of record on Tuesday, September 22nd were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date was Tuesday, September 22nd. Amphenol’s payout ratio is currently 25.00%.

Insider Buying and Selling

In other news, EVP David Silverman sold 240,000 shares of the company’s stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $87.12, for a total value of $20,908,800.00. Following the completion of the sale, the executive vice president owned 31,344 shares of the company’s stock, valued at $2,730,689.28. This represents a 88.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Richard Norwitt sold 372,208 shares of the company’s stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $81.14, for a total value of $30,199,096.08. Following the completion of the transaction, the chief executive officer owned 1,728,354 shares of the company’s stock, valued at approximately $140,230,001.79. This represents a 17.72% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 2,098,608 shares of company stock worth $172,316,688 over the last three months. 1.42% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in APH. Corient Private Wealth LP increased its position in shares of Amphenol by 3,010.0% during the second quarter. Corient Private Wealth LP now owns 16,437,431 shares of the electronics maker’s stock worth $2,898,248,000 after acquiring an additional 15,908,901 shares during the last quarter. State Street Corp lifted its stake in shares of Amphenol by 24.2% in the second quarter. State Street Corp now owns 71,281,059 shares of the electronics maker’s stock worth $12,107,146,000 after acquiring an additional 13,884,641 shares in the last quarter. Jupiter Topco LLC purchased a new position in Amphenol in the second quarter valued at about $1,600,531,000. Wellington Management Group LLP boosted its holdings in Amphenol by 10.5% in the second quarter. Wellington Management Group LLP now owns 16,579,919 shares of the electronics maker’s stock valued at $2,923,371,000 after purchasing an additional 1,578,248 shares during the last quarter. Finally, James Hambro & Partners LLP grew its stake in Amphenol by 97.5% during the 3rd quarter. James Hambro & Partners LLP now owns 2,774,794 shares of the electronics maker’s stock valued at $234,026,000 after purchasing an additional 1,369,512 shares in the last quarter. 97.01% of the stock is currently owned by hedge funds and other institutional investors.

About Amphenol

Amphenol Corporation (NYSE: APH) is a global manufacturer of electrical, electronic and fiber-optic connectors, interconnect systems and related products. Its portfolio includes cable assemblies, sensors, antennas, backplane systems, radio-frequency components and other specialized electronic hardware.

The company serves customers across a range of industries, including automotive, aerospace and defense, information technology and data communications, industrial, mobile networks, commercial aerospace, medical and other markets.